Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Other Operating Expenses (2023 - 2025)

Historic Other Operating Expenses for Krystal Biotech (KRYS) over the last 3 years, with Q3 2025 value amounting to $4.3 million.

  • Krystal Biotech's Other Operating Expenses changed N/A to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year increase of 9525.39%. This contributed to the annual value of $100.0 million for FY2023, which is N/A changed from last year.
  • As of Q3 2025, Krystal Biotech's Other Operating Expenses stood at $4.3 million.
  • Krystal Biotech's Other Operating Expenses' 5-year high stood at $100.0 million during Q3 2023, with a 5-year trough of $2.4 million in Q1 2024.
  • Over the past 3 years, Krystal Biotech's median Other Operating Expenses value was $5.5 million (recorded in 2024), while the average stood at $20.8 million.
  • The largest annual percentage gain for Krystal Biotech's Other Operating Expenses in the last 5 years was 10785.45% (2025), contrasted with its biggest fall of 1923.78% (2025).
  • Quarter analysis of 3 years shows Krystal Biotech's Other Operating Expenses stood at $100.0 million in 2023, then tumbled by 93.99% to $6.0 million in 2024, then dropped by 29.06% to $4.3 million in 2025.
  • Its Other Operating Expenses stands at $4.3 million for Q3 2025, versus $7.2 million for Q2 2025 and $5.0 million for Q1 2025.